Your browser version may not work well with NCBI's Web applications. More information here...
Items 1 - 20 of 1516
of 76Next
1:

The Directly Observed Therapy Short-Course (DOTS) strategy in Samara Oblast, Russian Federation.

Balabanova Y, Drobniewski F, Fedorin I, Zakharova S, Nikolayevskyy V, Atun R, Coker R.

Respir Res. 2006 Mar 23;7:44.

PMID: 16556324 [PubMed - indexed for MEDLINE]

2:

Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries.

Espinal MA, Kim SJ, Suarez PG, Kam KM, Khomenko AG, Migliori GB, Baéz J, Kochi A, Dye C, Raviglione MC.

JAMA. 2000 May 17;283(19):2537-45.

PMID: 10815117 [PubMed - indexed for MEDLINE]

3:

[Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis]

Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H.

Kekkaku. 2003 Oct;78(10):611-7. Japanese.

PMID: 14621568 [PubMed - indexed for MEDLINE]

4:

API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.

API Consensus Expert Committee.

J Assoc Physicians India. 2006 Mar;54:219-34.

PMID: 16800350 [PubMed - indexed for MEDLINE]

5:

Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy.

Migliori GB, Espinal M, Danilova ID, Punga VV, Grzemska M, Raviglione MC.

Int J Tuberc Lung Dis. 2002 Oct;6(10):858-64.

PMID: 12365571 [PubMed - indexed for MEDLINE]

6:

Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia.

Ruddy M, Balabanova Y, Graham C, Fedorin I, Malomanova N, Elisarova E, Kuznetznov S, Gusarova G, Zakharova S, Melentyev A, Krukova E, Golishevskaya V, Erokhin V, Dorozhkova I, Drobniewski F.

Thorax. 2005 Feb;60(2):130-5.

PMID: 15681501 [PubMed - indexed for MEDLINE]

7:

Drug resistant tuberculosis in prisons in Azerbaijan: case study.

Coninx R, Pfyffer GE, Mathieu C, Savina D, Debacker M, Jafarov F, Jabrailov I, Ismailov A, Mirzoev F, de Haller R, Portaels F.

BMJ. 1998 May 9;316(7142):1423-5.

PMID: 9572751 [PubMed - indexed for MEDLINE]

8:

[Multiple drug resistance: a threat for tuberculosis control]

Cardoso EM.

Rev Panam Salud Publica. 2004 Jul;16(1):68-73. Portuguese.

PMID: 15333267 [PubMed - indexed for MEDLINE]

9:

Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999, after the implementation of directly observed treatment.

Kam KM, Yip CW.

Int J Tuberc Lung Dis. 2001 Sep;5(9):815-23.

PMID: 11573892 [PubMed - indexed for MEDLINE]

10:

Tuberculosis recurrence and mortality after successful treatment: impact of drug resistance.

Cox H, Kebede Y, Allamuratova S, Ismailov G, Davletmuratova Z, Byrnes G, Stone C, Niemann S, Rüsch-Gerdes S, Blok L, Doshetov D.

PLoS Med. 2006 Oct;3(10):e384.

PMID: 17020405 [PubMed - indexed for MEDLINE]

11:

Drug-resistant tuberculosis, clinical virulence, and the dominance of the Beijing strain family in Russia.

Drobniewski F, Balabanova Y, Nikolayevsky V, Ruddy M, Kuznetzov S, Zakharova S, Melentyev A, Fedorin I.

JAMA. 2005 Jun 8;293(22):2726-31.

PMID: 15941801 [PubMed - indexed for MEDLINE]

12:

Risk of acquired drug resistance during short-course directly observed treatment of tuberculosis in an area with high levels of drug resistance.

Cox HS, Niemann S, Ismailov G, Doshetov D, Orozco JD, Blok L, Rüsch-Gerdes S, Kebede Y.

Clin Infect Dis. 2007 Jun 1;44(11):1421-7. Epub 2007 Apr 24.

PMID: 17479936 [PubMed - indexed for MEDLINE]

13:

Retreatment tuberculosis cases. Factors associated with drug resistance and adverse outcomes.

Kritski AL, Rodrigues de Jesus LS, Andrade MK, Werneck-Barroso E, Vieira MA, Haffner A, Riley LW.

Chest. 1997 May;111(5):1162-7.

PMID: 9149564 [PubMed - indexed for MEDLINE]

14:

Prevalence of multidrug-resistant pulmonary tuberculosis in counties with different duration of DOTS implementation in rural China.

Hu Y, Mathema B, Wang W, Hoffner S, Kreiswirth B, Xu B.

Microb Drug Resist. 2008 Sep;14(3):227-32.

PMID: 18707239 [PubMed - indexed for MEDLINE]

15:

Encouraging outcomes in the first year of a TB control demonstration program: Orel Oblast, Russia.

Kherosheva T, Thorpe LE, Kiryanova E, Rybka L, Gerasichev V, Shulgina M, Nemtsova E, Aptekar T, Kluge H, Jakubowiak W, Grzemska M, Aquino G, Wells C, Kazionny B.

Int J Tuberc Lung Dis. 2003 Nov;7(11):1045-51.

PMID: 14598963 [PubMed - indexed for MEDLINE]

16:

[Tuberculosis in Asia]

[No authors listed]

Kekkaku. 2002 Oct;77(10):693-7. Japanese.

PMID: 12440145 [PubMed - indexed for MEDLINE]

17:

Development of acquired drug resistance in recurrent tuberculosis patients with various previous treatment outcomes.

Yoshiyama T, Yanai H, Rhiengtong D, Palittapongarnpim P, Nampaisan O, Supawitkul S, Uthaivorawit W, Mori T.

Int J Tuberc Lung Dis. 2004 Jan;8(1):31-8.

PMID: 14974743 [PubMed - indexed for MEDLINE]

18:

An epidemiological study of tuberculosis and HIV infection in Tanzania, 1991-1993.

Chum HJ, O'Brien RJ, Chonde TM, Graf P, Rieder HL.

AIDS. 1996 Mar;10(3):299-309.

PMID: 8882670 [PubMed - indexed for MEDLINE]

19:

Prevalence of drug resistance under the DOTS strategy in Hyderabad, South India, 2001-2003.

Anuradha B, Aparna S, Hari Sai Priya V, Vijaya Lakshmi V, Akbar Y, Suman Latha G, Murthy KJ.

Int J Tuberc Lung Dis. 2006 Jan;10(1):58-62. Erratum in: Int J Tuberc Lung Dis. 2006 Jun;10(6):708. Priya, VHS [corrected to Hari Sai Priya, V]; Lakshmi, VV [corrected to Vijaya Lakshmi, V]; Latha, GS [corrected to Suman Latha, G].

PMID: 16466038 [PubMed - indexed for MEDLINE]

20:

Drug-resistant pulmonary tuberculosis in western Turkey: prevalence, clinical characteristics and treatment outcome.

Surucuoglu S, Ozkutuk N, Celik P, Gazi H, Dinc G, Kurutepe S, Koroglu G, Havlucu Y, Tuncay G.

Ann Saudi Med. 2005 Jul-Aug;25(4):313-8.

PMID: 16212125 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 1516
of 76Next